| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.2M | — | -12.8% |
| R&D Expense | $14.9M | — | +0.3% |
| SG&A Expense | $4.7M | — | +3.9% |
| Operating Income | -$11.4M | — | -14.4% |
| Net Income | -$9.1M | — | -3.0% |
| EPS (Basic) | -$0.54 | — | +53.8% |
| EPS (Diluted) | -$0.54 | — | +53.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.1M | -46.8% | +32.9% |
| Accounts Receivable | $451K | -53.7% | — |
| Current Assets | $232.6M | -8.6% | +143.5% |
| Total Assets | $235.5M | -8.6% | +137.8% |
| Current Liabilities | $35.0M | -28.3% | -24.9% |
| Total Liabilities | $36.9M | -27.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | +5.7% |
| Capital Expenditures | $19K | — | — |
| Investing Cash Flow | -$5.4M | — | -181.7% |
| Financing Cash Flow | $149K | — | -92.2% |
| Free Cash Flow | -$22.1M | — | +5.6% |
| -48.7% |
| Stockholders' Equity | $198.6M | -3.9% | +632.0% |